Measures of Overall Illness Severity and Burden for ME/CFS: A Scoping Review
The Patient - Patient-Centered Outcomes Research · 15.10.2026
DOI: 10.1007/s40271-026-00849-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Patient - Patient-Centered Outcomes Research, online erschienen am 15.10.2026. Verfasst von Jada Cripe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Community Research, DePaul University, Chicago, IL, USA. Jcripe1@depaul.edu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: The ME Association.
Abstract (Originalsprache)
Background and Objectives Consensus has not been established on measures of illness severity and burden for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), which is characterized by a wide range of symptoms including post-exertional malaise, unrefreshing sleep, and cognitive impairment. A scoping review was conducted to systematically evaluate the measurement of illness severity and burden in individuals with ME/CFS.
Methods
A literature search was conducted following PRISMA-ScR guidelines across five academic databases and one patient-organization-led website (with no restrictions on publication date; restricted to English language studies, and excluding review articles). Records were imported into Covidence, a systematic and scoping review data management tool, with studies retained if they evaluated an ME/CFS population and explicitly measured illness severity or illness burden. Information from each source was extracted and relevant measures were evaluated.
Results
From the reviewed literature, 190 full-text articles met the final inclusion criteria and were retained for analysis. The most frequently utilized tools for evaluating illness severity and burden in individuals with ME/CFS were the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and the Sickness Impact Profile (SIP). Additional prominent instruments identified across the literature include disease-specific measures such as the DePaul Symptom Questionnaire (DSQ) and generic health-related quality of life indices like the EuroQoL 5-Dimension (EQ-5D-5L).
Conclusions
Significant discrepancies persist in how illness severity and illness burden are operationalized in ME/CFS research. The reliance on generic instruments often obscures core symptom domains like post-exertional malaise (PEM), while inconsistent standards limit cross-comparability. Establishing standardized, disease-specific illness metrics is critical to accurately capturing the true burden of illness and advancing rigorous clinical research.
Autor:innen und Institutionen
- Center for Community Research, DePaul University, Chicago, IL, USA. Jcripe1@depaul.edu.
- Center for Community Research, DePaul University, Chicago, IL, USA.
Förderung
- The ME Association
Zitieren
APA
Cripe, J., Ravichandran, S., Deditz, S., & Jason, L. A. (2026). Measures of Overall Illness Severity and Burden for ME/CFS: A Scoping Review. The Patient - Patient-Centered Outcomes Research. https://doi.org/10.1007/s40271-026-00849-8
Vancouver
Cripe J, Ravichandran S, Deditz S, Jason LA. Measures of Overall Illness Severity and Burden for ME/CFS: A Scoping Review. The Patient - Patient-Centered Outcomes Research. 2026. doi:10.1007/s40271-026-00849-8
BibTeX
@article{Cripe2026,
author = {Cripe, Jada and Ravichandran, Suvetha and Deditz, Samantha and Jason, Leonard A},
title = {Measures of Overall Illness Severity and Burden for ME/CFS: A Scoping Review},
journal = {The Patient - Patient-Centered Outcomes Research},
year = {2026},
doi = {10.1007/s40271-026-00849-8}
}
EUVIMED